Literature DB >> 15823498

Epidemiology of adult rheumatoid arthritis.

Yannis Alamanos1, Alexandros A Drosos.   

Abstract

Several incidence and prevalence studies of rheumatoid arthritis (RA) have been reported during the last decades, suggesting a considerable variation of the disease occurrence among different populations. The majority of studies carried out in Northern European and North American areas estimate a prevalence of 0.5-1%, and a mean annual incidence of 0.02-0.05%. The occurrence of the disease seems to be lower in other parts of the world. Some studies from North American, North European, and Japanese populations suggest a decline in both the prevalence and incidence of the disease after the 1960s. RA is related to an increased mortality, and the expected survival of RA patients is likely to decrease 3-10 years. There is epidemiological evidence that genetic factors are related to an increased risk of RA. However, RA is considered to be a multifactorial disease, resulting from the interaction of both genetic and environmental factors, which contribute to its occurrence and expression. The main risk factors for the disease include genetic susceptibility, sex and age, smoking, infectious agents, hormonal, dietary, socioeconomic, and ethnic factors. Most of these factors are likely to be associated with both disease occurrence and severity.

Entities:  

Mesh:

Year:  2005        PMID: 15823498     DOI: 10.1016/j.autrev.2004.09.002

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  231 in total

1.  What is the ability of anti-cyclic citrullinated peptide antibodies determination in synovial fluid in discriminating rheumatoid arthritis from non-rheumatoid arthritis patients? A Tunisian cross-sectional study.

Authors:  Dalila Mrabet; Lilia Laadhar; Héla Sahli; Béchir Zouari; Slim Haouet; Houria Lahmar; Sondes Makni; Slaheddine Sellami
Journal:  Clin Rheumatol       Date:  2011-09-28       Impact factor: 2.980

Review 2.  Immune-mediated inflammatory diseases (IMIDs) and biologic therapy: a medical revolution.

Authors:  Annabel Kuek; Brian L Hazleman; Andrew J K Ostör
Journal:  Postgrad Med J       Date:  2007-04       Impact factor: 2.401

3.  Genetic variants associated with complex human diseases show wide variation across multiple populations.

Authors:  A Adeyemo; C Rotimi
Journal:  Public Health Genomics       Date:  2009-05-13       Impact factor: 2.000

4.  Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs.

Authors:  Kurt Richard Brekke; Dag Morten Dalen; Tor Helge Holmås
Journal:  Eur J Health Econ       Date:  2013-10-22

Review 5.  The role of lymphotoxin-α in rheumatoid arthritis.

Authors:  Tomohiro Hirose; Yuri Fukuma; Ayumu Takeshita; Keiichiro Nishida
Journal:  Inflamm Res       Date:  2018-03-14       Impact factor: 4.575

6.  Computer-aided and manual quantifications of MRI synovitis, bone marrow edema-like lesions, erosion and cartilage loss in rheumatoid arthritis of the wrist.

Authors:  Haitao Yang; Julien Rivoire; Michael Hoppe; Waraporn Srikhum; John Imboden; Thomas M Link; Xiaojuan Li
Journal:  Skeletal Radiol       Date:  2014-12-10       Impact factor: 2.199

7.  Prevalence and incidence of rheumatoid arthritis in South Korea.

Authors:  Yoon-Kyoung Sung; Soo-Kyung Cho; Chan-Bum Choi; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2012-12-20       Impact factor: 2.631

Review 8.  Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review.

Authors:  Nurullah Akkoc
Journal:  Curr Rheumatol Rep       Date:  2008-10       Impact factor: 4.592

9.  Recommendations and the state of the evidence for physical activity interventions for adults with rheumatoid arthritis: 2007 to present.

Authors:  Maura D Iversen; Marisa Brawerman; Christina N Iversen
Journal:  Int J Clin Rheumtol       Date:  2012-10-01

Review 10.  B-cell survival factors in autoimmune rheumatic disorders.

Authors:  Sandra A Morais; Andreia Vilas-Boas; David A Isenberg
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-08       Impact factor: 5.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.